Pioneering research to fight
pulmonary fibrosis and lung infection

Donate

The work of our fantastic team includes both pre-clinical research and clinical trials to develop a comprehensive body of knowledge in interstitial lung diseases, including pulmonary fibrosis, and lung infection, including bronchiectasis, and COVID-19.

A clinical study involves research using human volunteer participants that is intended to add to medical knowledge. All clinical trials of new drugs, vaccines, devices or methods need to go through a series of phases to test whether they’re safe and whether they work.

Currently Recruiting Studies

Study Name Focus Length Phase Link
Mechanisms of Lung Injury and Repair IPF and lung disease One study visit Pre-Clinical Learn more
TIPAL IPF 12 months III Learn more
XTMAB-16-201 Sarcoid 12-24 weeks Ib/II Learn more
FIBRONEER-SARD SARD-ILD 27 weeks IIIb Learn more
CHORUS FHP 34 weeks III Learn more
         

See how your donations have contributed to our ground-breaking research

2025 ILD Research Report

Sign up!

Receive our latest research updates and news

  • This form collects your name and email address so that we can keep you updated with news and information about Breathing Matters. Please check our Privacy Policy to see how we protect and manage your data.

Sign up to receive our news and updates

  • This form collects your name and email address so that we can keep you updated with news and information about Breathing Matters. Please check our Privacy Policy to see how we protect and manage your data.

Where there's research there's hope

Research into respiratory conditions accounts for just 2% of all the medical research funding in the UK.

Will you support our research?